just watching and holding
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AgraFlora Organics Provides Q3 2019 - Q4 2020 Guidance for ACMPR Licensed AAA Heidelberg Facility
VANCOUVER, June 14, 2019 /CNW/ - AgraFlora Organics International Inc. ("AgraFlora" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to provide the following Q3 2019 – Q4 2020 operating guidance pertaining to its wholly owned AAA Heidelberg Facility ("AAA Heidelberg") including:
•Application and anticipated receipt of a Health Canada awarded Sales License;
•Application and anticipated receipt of a Health Canada awarded Processing License;
•Application and anticipated receipt of a Health Canada issued Export permit;
•Proposed on-site dispensary as per Alcohol and Gaming Commission of Ontario ("AGCO") regulations;
?Potential 1,500,000-purchaser catchment area within a 90-minute radius
•Importation of a catalogue of premium craft cannabis genetics;
•Fully optimized production capabilities of circa 1,000,000 grams of ultra-premium dried craft cannabis flower, with potential production expansion based off surplus cultivation areas contemplated;
•Successful recapture of 225,000 grams of premium cannabis trim to be manufactured into ancillary value-added cannabis products;
•Successful harvest of inaugural ultra-premium craft cannabis crop; and,
•Proposed export of finished cannabis form factors to emerging marketplaces, including India and Thailand, achieving unit contribution of up to $15 per gram.
AgraFlora Organics International Inc. (CNW Group/AgraFlora Organics International Inc.)
AAA Heidelberg is a licenced cannabis cultivation facility under Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The AAA Heidelberg facility is equipped with five partitioned flower rooms, affording the Company ample canopy earmarked for ultra-premium craft cannabis cultivation.
The Company is presently working to import a catalogue of premium craft cannabis genetics into its AAA Heidelberg facility, under a one-time declaration from Health Canada. Upon successful importation, AgraFlora plans to initiate its first crop of ultra-premium cannabis at the London-based AAA Heidelberg facility.
Internal projections indicate that once fully optimized the AAA Heidelberg facility may achieve annualized dried cannabis production capabilities of circa 1,000,000 grams, including the successful recapture of 225,000 grams of premium cannabis trim to be manufactured into ancillary value-added cannabis products.
Brandon Boddy, Chief Executive Officer and Chairman of AgraFlora stated: "Successful receipt of a Health Canada awarded Export Permit, coupled with a Processing License and a Sales License will arm AAA Heidelberg with the ability export finished cannabis form factors into various emerging, high-profile cannabis jurisdictions such as India and Thailand, thus solidifying a distinctive first mover advantage, while realizing generous product margins. In conjunction with the Company's many other initiatives within the international cannabis vertical supply chain, it is anticipated that AAA Heidelberg will support revenue generation as early as Q1 2020."
Concurrently, the Company plans to apply to Health Canada for both sales and processing licenses, with the objective of producing finished cannabis form factors for domestic distribution including, but not limited to high margin products such as soft gels, tinctures, distillates and THC oils. AgraFlora also plans to conduct full analytical testing on terpene profiling and residual solvents for authorized clients upon application and receipt of appropriate licensing from Health Canada.
Furthering its vertically integrated mandate, AgraFlora is also contemplating establishing an on-site dispensary at the AAA Heidelberg facility, as per Alcohol and Gaming Commission of Ontario ("AGCO") regulations, capitalizing on a 1,500,000-purchaser catchment area within a 90-minute radius.
London, Ontario is Canada's 11th largest metropolitan area and is tactical located at the nexus of Toronto, Ontario, Detroit, Michigan and Buffalo, New York; affording the Company a lucrative opportunity to capture a significant portion of the cannabis tourism marketplace.
The Company is also considering submitting an application under Health Canada's Cannabis Act and Cannabis Regulations in accordance with Subsection 11(5) of the Cannabis Regulations, which would permit the Company to engage in the following value added activities:
•The sale and distribution of dried cannabis, fresh cannabis, cannabis plants and cannabis plant seeds to any of the following licence holders: micro cultivation, standard cultivation, processing, analytical testing, research or cannabis drug licence;
•The sale and distribution of cannabis plants and cannabis plant seeds to a holder of a licence for a nursery;
•The sale and distribution of cannabis plants and cannabis plant seeds, that are cannabis products, to: a holder of a licence for sale, or a person authorized to sell cannabis under a provincial act by reason of Subsection 69(1) of the act;
•The sale and delivery of cannabis plants and cannabis plant seeds, that are cannabis products, to the purchaser of the products at the request of: a person authorized to sell cannabis under a provincial act by reason of Subsection 69(1) of the act, or a holder of a licence for sale.
Successful receipt of the above stated license would allow AgraFlora to immediately engage in business-to-business ("B2B") sales to its strategic partners and/or other qualified licence holders under the Cannabis Act and Cannabis Regulations.
In addition, AgraFlora's AAA Heidelberg facility has begun preparations to submit an application package for an Export permit under Health Canada's Cannabis Act and Cannabis Regulations. The Company anticipates successful receipt of an Export Permit in the next 120 calendar days, granting it the unique ability to permeate emerging locales with craft cannabis products at unit contributions of up to $15 per gram.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Brandon Boddy
Chairman & CEO
T: (604) 682-2928
The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.
Forward-looking Information Cautionary Statement
This press release contains forward-looking information or forward-looking statements (collectively "forward-looking information") within the meaning of applicable securities laws. Forward-looking information is frequently characterized by words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" "is on track" and similar references to future periods.. Forward-looking information is neither historical facts nor assurances of future performance. Instead, it is based only on the Company's current beliefs, expectations and assumptions regarding the future of the Company's business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control including, but not limited to delays or uncertainties with corporate or regulatory approvals, including approvals of the Canadian Securities Exchange, Health Canada or other applicable domestic and international regulatory bodies. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any forward-looking information. There are no assurances that the business plans for AgraFlora Organics described in this news release will come into effect on the terms or time frames described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which are available at www.sedar.com.
SOURCE AgraFlora Organics International Inc.
Ateba Signs Binding LOI with Glow LifeTech
Toronto, Ontario--(Newsfile Corp. - April 9, 2019) - Ateba Resources Inc. (the "Company") is pleased to announce that it has entered into a binding letter of intent (the "LOI") with Glow LifeTech Ltd. ("Glow") whereby Ateba will acquire all of the securities of Glow by way of a three-cornered amalgamation, subject to the terms and conditions of the LOI (the "Proposed Transaction"). Pursuant to the terms of the Proposed Transaction, Glow will amalgamate with a wholly-owned subsidiary of Ateba, and Ateba will change its name to "Glow LifeTech Corp.". As a result of the Proposed Transaction, Ateba will continue on with the business of Glow. Glow is responsible for a termination fee of $100,000 in the event Glow breaches the terms of the LOI. Ateba has no commercial operations, no assets and minimal liabilities. Ateba has no commercial operations, no assets and minimal liabilities.
Ateba is a reporting issuer in the Provinces of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec and its common shares (the "Ateba Shares") are not currently listed on any exchange or market. The Company will provide an update of the Proposed Transaction in a press release at a later date.
Under the terms of the LOI, Glow will complete a minimum financing of $500,000 through the issuance of 2,500,000 common shares prior to the closing of the Proposed Transaction. Additionally, Ateba will complete a 1.5555555 for 1 share consolidation prior to the closing of the Proposed Transaction.
Glow is currently owned 63.5% by Relay Medical Corp. and 36.5% by AgraFlora Organics International Inc. With initial funding of at least $500,000 prior to the closing of the Proposed Transaction, Glow will establish its operational structure with a mandate to build its current smart cannabis software and to find and identify appropriate technology opportunities within the cannabis sector. Glow has commenced initial due diligence on industry related innovative technologies. After the completion of the Proposed Transaction and the contemplated listing, Glow will be positioned to advance and fund its business model with access to public capital markets.
Resulting Capitalization
After completion of the Proposed Transaction, and assuming no further common shares are issued, an aggregate of 15,500,000 common shares in the capital of Ateba (the "Ateba Shares") will be issued and outstanding, with former securityholders of Glow holding 12,500,000 Ateba Shares, representing approximately 80% of the total outstanding Ateba Shares and the original shareholders of Ateba holding 3,000,000 Ateba Shares, representing approximately 20% of the outstanding Ateba Shares. The closing date for the Proposed Transaction is expected to be on or around June 30, 2019.
Management and Board of Directors
Upon completion of the Proposed Transaction, the board of directors and management of the resulting issuer will consist of the persons identified below:
W. Clark Kent - President & Chief Executive Officer, Director
Clark is a capital markets professional with extensive experience leading corporate development and finance initiatives in the natural resources, technology and life science industries. For over a decade he has advised emerging companies on strategic planning, finance and recruitment in the North American and international marketplace. Since January 2018 Clark has served as President of MedTech accelerator Relay. Clark began his career with a boutique investment firm where he focused on client relations and marketing.
Chris Hopkins - Chief Financial Officer
Chris has over 25 years of leadership and financial management experience in the capital markets. He has spent most of his career in senior roles with public mining companies, including U.S. Silver, Rio Algom, BHP Billiton, Suncor and several Canadian and international companies. He has a Bachelor of Commerce from the University of Toronto, and a Chartered Accountant designation and MBA from the Schulich School of Business at York University.
Derek Ivany - Director
Mr. Derek Ivany was appointed President and Chief Executive Officer of AgraFlora in April 2016 and was instrumental at leading the company away from its resource past to become a large-scale cannabis producer on the world stage. As a public company consultant, Mr. Ivany has worked with numerous publicly traded companies across many different industries. He began his career in investor relations, marketing and corporate development in the oil & gas industry. He transitioned into the junior resource and mining section and most recently to technology and cannabis industries where he has continued to excel. Mr. Ivany continues to be active in both private and public capital markets and is considered an international influencer in the emerging global cannabis industry.
Medhanie Tekeste - Director
Mr. Tekeste is an executive with over 20 years of information systems experience including many years of broad-based management expertise in systems development, implementation and support. He is experienced in strategically and cost effectively utilizing technology to achieve corporate goals. He has extensive global experience in service delivery in the pharmaceutical industry including Quality, Manufacturing and R&D processes. Medhanie also has considerable experience in laboratory quality assurance testing and computer systems validation. Currently, he is the Chief Information Officer at Apotex Inc., where he is responsible for delivery of all end to end IT services globally, including Enterprise Architecture, Cloud and platform services, Service Design, Data Governance, Software Quality Assurance and Security Management, Governance, Program Management and Business Enablement.
Chris Irwin - Director
Chris Irwin practices securities and corporate/commercial law and has been the managing partner of Irwin Lowy LLP since January 2010; prior thereto he was the President of Irwin Professional Corporation from August 2006 to December 2009; and prior thereto he was an associate at Wildeboer Dellelce LLP from January 2004 to July 2006. Mr. Irwin advises a number of public companies, board of directors and independent committees on a variety of issues. Mr. Irwin is a director and/or officer of a number of public companies. Mr. Irwin is a former Director of Trelawney Mining and Exploration Inc., a company acquired by IAMGOLD Corporation in a $608 million transaction; former Director of Southern Star Resources Inc., which was formerly listed on TSX prior to becoming Gold Eagle Mines Ltd. and being taken over by Goldcorp Inc. in a $1.5 billion transaction
Ateba Resources Inc.
Ateba is a reporting issuer in the Provinces of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec and its common shares (the "Ateba Shares") are not currently listed on any exchange or market. The Company will provide an update on the Proposed Transaction and public listing process in a press release at a later date.
Glow LifeTech Ltd.
Glow is a private company founded by Relay and AgraFlora in December 2018 to pursue technology opportunities in the global cannabis sector. The newly formed entity combines Relay's techno-commercial leadership with AgraFlora's accumulated knowledge, expertise and access to cannabis industries across the sector. Glow will benefit from Relay's infrastructure, technical leadership and business knowledge for the research, vetting, product development and validation of innovative technologies and AgraFlora will support the Company in the pursuit of technology opportunities in scientific validation, diagnostics, health & safety, screening, compliance and quality control/assurance within the cannabis industry.
For more information visit mscience.ca
For more information, please contact:
Lisa McCormack
Chief Executive Officer
Tel: (416) 361-2515
Neither the CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
This news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/43986
Natures Hemp Moves Hemp Based Coffee Creamer to Second Phase of Development
Canada NewsWire
VANCOUVER, Feb. 4, 2019
VANCOUVER, Feb. 4, 2019 /CNW/ - AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) (the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce that Natures Hemp Corp. ("Natures Hemp"), a spin-off company from PUF Ventures and a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets, is moving forward with the development of a hemp based coffee creamer. The Richardson Centre of Functional Foods and Nutraceuticals at the University of Manitoba is undertaking phase two of product development which includes product and process optimization, increased production scale plus a shelf life study.
AgraFlora Organics International Inc. (CNW Group/AgraFlora Organics International Inc.)
"We are moving to phase two of the development of our all-natural, hemp-based, non-dairy coffee creamer to increase production scale, introduce alternative flavours and study the nutrient composition and shelf life of the new product," said Derek Ivany, President and CEO of AgraFlora Organics International. "Initial tests show that our new coffee creamer tastes good, has all the characteristics of conventional creamers and includes all the healthy benefits of cannabidiols. More news will follow as we add to the management team and provide more specific timing to the public listing process."
Nature Hemp's healthy alternative non-dairy coffee creamer is made using whole hemp seeds. Hemp seeds are recognized as a superfood, like flax and chia seeds, because they contain cannabidiol (CBD), are high in protein, contain 20 amino acids, and are also high in the fatty acids omega-3 and omega-6. Hemp seeds are typically pressed to produce oil and the remaining byproduct is processed into a flour from which products like pasta, baked goods and other healthy foods can be created.
Natures Hemp is focused at unlocking the true value of hemp by developing a new generation of plant-based, nutrient rich CBD food, beverage and healthcare related products.
The plan of arrangement creating Natures Hemp was completed on August 28, 2018, when it became an independent company and a private issuer. Management is preparing the company to go public on a Canadian stock exchange.
About Natures Hemp Corp.
Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2019/04/c0468.html
AgraFlora Organics International Inc., Tim McNulty, E: ir@agraflora.com, T: (800) 783-6056Copyright CNW Group 2019
AgraFlora Organics Announces Media and Investor Tour of Large-Scale Greenhouse in Delta, BC and Posts Corporate Video
Canada NewsWire
VANCOUVER, Jan. 25, 2019
VANCOUVER, Jan. 25, 2019 /CNW/ - AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) (the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce its joint venture partner company Propagation Service Canada will be hosting a media and investor tour of the 2,200,000 square foot greenhouse in Delta, BC, as it is being converted to grow high-quality medicinal and recreational cannabis. As a preview the Company has prepared a short but impressive video that captures the sheer size of the operation. Visit www.agraflora.com to view the video.
Delta Greenhouse Complex
Presentation & Tour
Mid-March 2019
Open to Media, Industry Analysts, Shareholders, Investors and other interested parties.
AgraFlora Organics International (CNW Group/AgraFlora Organics International Inc.)
The date and time of the tour is to be confirmed. Please rsvp your interest in attending by sending an email to ir@agraflora.com.
"The Delta Greenhouse Complex is truly an impressive operation and although the video provides a great view of the complex, an actual tour of the facility is the only way to capture its absolute size," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "I applaud the work by Casey Houweling and his team on the progress made to date at the greenhouse. The project remains on schedule, on budget, and the tour will highlight the production capabilities of the complex and provide an inside glimpse of a high tech and high-quality cannabis cultivation operation."
Propagation Services Canada is the joint venture company in the process of retrofitting the large-scale greenhouse complex in Delta, BC. The fully funded retrofit of the 2,200,000 square foot complex is to be completed in three phases:
•Phase 1 includes the retrofit of 350,000 square feet, including 100,000 post-production facilities, completion scheduled for Q2 2019;
•Phase 2 includes an additional 1,450,000 square feet to be completed by Q4 2019;
•Phase 3 consists of 400,000 square feet scheduled for completion in Q2 2020.
The Delta greenhouse complex includes advanced growing systems for greenhouse HVAC, watering and lighting. It includes its own natural gas co-gen energy plant which provides cost effective electricity for lighting and heating of the large-scale greenhouse. The result is highly efficient and one of the most cost-effective growing operations in the industry.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/25/c5141.html
AgraFlora Organics International Inc., E: ir@agraflora.com, T: (778) 945-0348Copyright CNW Group 2019
AgraFlora Organics Wholly Owned Subsidiary AAA Heidelberg Inc. to Acquire High Quality Cannabis Strains
Canada NewsWire
VANCOUVER, Jan. 22, 2019
VANCOUVER, Jan. 22, 2019 /CNW/ - AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) (the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce its wholly owned subsidiary, AAA Heidelberg Inc. is preparing to acquire a high-quality strain of cannabis to begin cultivation at its 8,800 square foot facility in London, Ontario.
AgraFlora Organics International Inc. (CNW Group/AgraFlora Organics International Inc.)
"After receiving our license in October, we have been working to prepare the facility in London and identify the premiere stain for our first crop of high-quality boutique cannabis," said Chris Hornung, President of AAA Heidelberg Inc. "AAA is a boutique, small-batch, craft grower and our strategy is to produce high-quality cannabis with unique genetics demanding a premium price. Our team is in place, the facility is ready to go, and we are in the process of finalizing a distinct strain of high-quality cannabis. We are very excited to be procuring the seedlings to begin our first crop and look forward to a very productive year in 2019."
"With AAA Heidelberg and Propagation Services Canada both preparing for their first cannabis crops, AgraFlora will begin generating significant revenues in 2019," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "Our business in Canada is taking shape and we will soon have more than 250,000 square feet of growing area under cannabis production. We can now move our focus to the international markets where we have made considerable progress in Europe. We are also focusing on improving our extensive genetic library by adding unique cannabis genetics from Latin America. I have been in Colombia for a number of weeks sourcing exotic cannabis genetics/strains and will have more to announce in the near future."
AAA Heidelberg owns an 8,800 square foot indoor growing facility in London, Ontario. The facility has the most up-to-date growing and security technologies available and meets the highest level of pharmaceutical standards. It features a state-of-the-art HVAC system, a Surna Water Chilled Climate Control system and a security system that meets or exceeds all requirements demanded by Health Canada. These systems are backbone of the facility's automated control for the complete operations of the growing process.
This announcement follows the Health Canada grant of a cultivation license to AAA Heidelberg on October 15, 2018 and the acquisition of the remaining interest in AAA Heidelberg by AgraFlora on December 15, 2018.
In Delta, BC AgraFlora continues to work with its joint venture partners to convert an existing 2,200,000 square foot tomato greenhouse complex to cannabis production. The first phase of the retrofit is on schedule to complete 250,000 sq. ft. of flowering area by the summer of 2019. Propagation Services Canada intends on completing the total of 1,700,000 sq. ft. of flowering area by the end of 2019 and the final phase of the greenhouse retrofit is planned to include an additional 450,000 sq. ft. of flowering area scheduled for completion in the summer of 2020.
On January 7, 2019 the Company announced that management had initiated discussions regarding supply agreements and product development partnerships with several European Union based pharma companies. The discussions have advanced on both fronts and the management team will be travelling to Europe in early February to finalize potential agreements.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/22/c6881.html
AgraFlora Organics International Inc., E: ir@agraflora.com, T: (778) 945-0348Copyright CNW Group 2019
unsure with what is going on with this stock. it can't even sustain .30. we need something good to happen with this stock, and soon. Friday today and it looks like we're going to settle around .20.
it looks like this stock is going to stay around the .30 cent range, at least for now. not too much till after the first quarter. thanks
Cannabis Companies Expanding Global Footprint; The Greater Cannabis Company Inc. (OTC:GCAN), Aphria, Canopy Growth and AgraFlora Organics
09 Jan 2019 08:00 ET
GlobeNewswire
Investorideas.com, a leading investor news resource covering cannabis stocks releases a snapshot looking at the global expansion of the cannabis industry and the companies looking at new international markets as regulations change.
As new international markets being to open, both cannabis giants as well as smaller cannabis technology companies are now making the necessary preparations to enter this international space.
The Greater Cannabis Company, Inc. (OTC:GCAN), recently announced that it has entered into a letter of intent with iCAN Cannabis to expand distribution of its eluting patch platform into key global markets. The eluting patch platform is an innovative delivery system which uses a patented mucoadhesive and multilayered orally dissolving thin film to deliver a precise dose of cannabinoids into the body through the buccal mucosa. Clinical studies, funded in part by the National Institutes of Health (NIH), have shown the delivery system's capability in achieving higher bioavailability and desired results in the body using lower and controlled dosing when compared to other routes of administration.
The agreement with iCAN will include commercial ready formulations to meet medical and recreational market demands. Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia and Portuguese territories.
In their recent news release, Aitan Zacharin, CEO of Greater Cannabis said, "I am pleased to announce our partnership with iCAN. Saul is an industry leader who is at the forefront of everything tech in cannabis. His desire to partner with us is a testament to the strength of our technology and its capabilities. We are excited to establish this important partnership in the medical and adult-use cannabis industry. We are focused on transactions that will accelerate commercialization of our products and the iCAN deal does that globally. iCAN shares our enthusiasm for seeing healthier, standardized, pharmaceutical-grade and more cost-effective cannabis products introduced into the market. We look forward to working with iCan to bring our cutting-edge technology to consumers worldwide."
Similarly, in December of 2018, Aphria Inc. (TSX:APHA.TO) (NYSE:APHA) and Rapid Dose Therapeutics Inc. announced that they have expanded the scope of their previously announced agreement where Aphria has been granted exclusive preferred rights to license, manufacture, distribute and sell RDT's QuickStrip(TM) innovative, proprietary delivery technology for the cannabis market to Germany.
In their news release, Jakob Ripshtein, President of Aphria commented that "Germany is one of the most sought-after cannabis markets today and Aphria continues to take a comprehensive approach to ensure a leading presence in the country as the opportunity evolves." Ripshtein continued, "Aphria is committed to bringing advanced products and innovations to cannabis markets around the world, and this agreement with RDT will enable us to bring QuickStrip(TM) technology to the German market and offer a unique nutraceutical product that delivers a consistent dosage."
Back in November, Canopy Growth Corp. (NYSE:CGC) (TSX:WEED.TO), one of the world's biggest medical cannabis companies announced they would spend more than 100 million euros (US$115 million) to expand production in the EU over the next two years, according to Pierre Debs, managing director at Canopy's Spectrum Cannabis Europe division.
In one news article, Debs commented that Germany and the EU overall "are the most exciting federally regulated medical cannabis markets outside of Canada." Debs continued in the phone interview saying, "Things are going to grow not too differently than what happened in Canada. We're going to need significant production facilities."
AgraFlora Organics International Inc. (CSE: AGRA) (OTCPK: PUFXF) has also been looking at the international sector with their recent announcement that they have engaged good manufacturing practices (GMP) facility experts to design post production exports for the European Union (EU) in preparation for the first crop of cannabis to be planted at its large-scale Delta Greenhouse Complex later this year. The Company has also initiated discussions regarding supply agreements and product development partnerships with several European Union based pharma companies.
In their recent release, Derek Ivany, President and CEO, AgraFlora Organics International Inc. said, "I am very pleased to announce we have engaged European GMP facility experts to design post production products for export markets."
As the world is watching the successes and struggles of the Canadian and US cannabis markets, there is an increasing need for companies to take the proper steps and make the investments or face the possibility of being left out of the global cannabis community.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
https://www.investorideas.com/About/
Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/
This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring GCAN is a paid for news creation service on Investorideas.com. Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800-665-0411
https://resource.globenewswire.com/media/36a5f87c-8022-4710-8657-40823b9d50b5/small/investorideas-jpg.jpg
<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzc0NzUwMzA=" alt="" width="1" height="1"/>
(C) Copyright 2019 GlobeNewswire, Inc. All rights reserved.
Chart not available
CNW Group
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce that it has engaged good manufacturing practices (GMP) facility experts to design post production exports for the European Union (EU) in preparation for the first crop of cannabis to be planted at its the large-scale Delta Greenhouse Complex later this year. The Company has also initiated discussions regarding supply agreements and product development partnerships with several European Union based pharma companies.
"I am very pleased to announce we have engaged European GMP facility experts to design post production products for export markets," said Derek Ivany, President and CEO, AgraFlora Organics International Inc. "The first 250,000 square feet of cultivation space at Propagation Services Canada's Delta Greenhouse Complex will be coming online in mid-2019 and it is important that we have multiple sales avenues for our final product. We have taken steps to establish our domestic distribution network and have initiated discussions with multiple pharma companies based in the European Union to establish an export market. We expect to make an further announcement regarding domestic and export supply and product development agreements in the first half of 2019."
AgraFlora's management team is actively establishing a customer base for its medical cannabis flower and propagating plants including the recently announced medical cannabis supply agreement with Namaste Technologies and propagation plant supply agreement with Cabbay Holdings Corp.
The European Union represents a significant opportunity for AgraFlora as it is home to more than 500 million people, a population significantly larger than the combined population of the United States and Canada--the two largest cannabis markets in the world today. The legalization of medical and recreational cannabis is gaining traction across Europe including Germany, one of the fastest-growing medical cannabis marketplaces in the world.
Propagation Services Canada is a joint venture company in the process of retrofitting a large-scale greenhouse complex in Delta, BC. The fully funded retrofit of the 2,200,000 square foot complex is to be completed in three phases:
-- Phase 1 includes the retrofit of 350,000 square feet, including
100,000 post-production facilities, completion scheduled for Q2
2019;
-- Phase 2 includes an additional 1,450,000 square feet to be
completed by Q4 2019;
-- Phase 3 consists of 400,000 square feet scheduled for
completion in Q2 2020.
The Delta greenhouse complex includes advanced growing systems for greenhouse HVAC, watering and lighting. It includes it own natural gas co-gen energy plant which provides cost effective electricity for lighting and heating of the large-scale greenhouse. The result is a highly efficient and one the most cost-effective growing operation in the industry.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/07/c3748.html
SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., Tim McNulty, E: ir@agraflora.com, T: (800)
783-6056
Copyright (C) 2019 CNW Group. All rights reserved.
Chart not available
Relay Medical Corp. and AgraFlora Organics International Inc. Form Glow Life Technologies Ltd. for the Development of Medical Technologies in the Cannabis Sector
20 Dec 2018 03:00 ET
CNW Group
Relay Medical Corp. ("Relay") (CSE: RELA, OTCQB: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, and AgraFlora Organics International Inc. ("AgraFlora Organics") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, and jointly referred to as the "Partners", are pleased to announce the formation of the private company Glow Life Technologies Ltd. ("Glow") to pursue medical related technology opportunities in the global cannabis sector.
The newly formed entity combines Relay Medical's techno-commercial leadership with AgraFlora Organic's accumulated knowledge, expertise and access to cannabis industries across the sector. Glow Life Technologies will benefit from Relay Medical's infrastructure, technical leadership and business knowledge for the research, vetting, product development and validation of innovative technologies and AgraFlora will support the Company in the pursuit of technology opportunities in scientific validation, diagnostics, health & safety, screening, compliance and quality control/assurance within the cannabis industry.
"The combination of a new industry with unbridled expansion has created a critical need for technology to support, enhance and maintain the quality, health and safety needs for cannabis use as a medicinal and controlled substance." said Derek Ivany, President & CEO of AgraFlora Organics International Inc. "The development of such technologies requires a level of sophistication and MedTech experience that is not yet commonplace in the industry, and we could not think of a better partner than Relay Medical and Lahav Gil to address this opportunity. We are very excited to join them in the path to recognizing Glow's full potential."
"The legalization and utilization of medical cannabis is in its infancy and the industry needs adequate technologies to properly validate and effectively control, screen, and regulate the substance for prescription and medical use," said Lahav Gil, CEO, Relay Medical Corp. "We believe that this gap presents significant opportunities within the MedTech industry and that creating Glow as a focused company will ultimately position it with the technical and industry expertise to build an innovation platform related to medical cannabis technologies. The Cannabis sector is grappling with its own identity and credibility, and we aim to bring clarity and focus into the MedTech ecosystem. We are very pleased to work with AgraFlora at such a crucial time in the industry as Canada positions itself for global leadership. We believe this partnership provides Glow with unprecedented benefits and expect that the company will take full advantage of these synergies.
The newly formed entity is owned 50% by Relay Medical, 30% by AgraFlora Organics, who have committed to an initial investment of $200,000, and 20% by private investors who have committed $500,000 investment in Glow Life Technologies Ltd. Total initial funding of $700,000 has launched Glow Life Technologies in the development of its operational structure, with the initial mandate to find and identify appropriate technology opportunities within the sector. Glow has commenced initial due diligence on industry related innovative technologies and expects to announce its management and industry expert support team early in 2019.
About Relay Medical Corp.
Relay Medical is an evolving "Integrated MedTech Accelerator" headquartered in Toronto, Canada, acquiring early-stage technologies and inventions, advancing and preparing them for pre-commercial acquisitions in the HealthTech marketplace. By integrating the funding, development and exit process into one organization led and managed by one expert team, Relay Medical is building the capacity to accelerate and transact technologies with high efficiency and grow into a leading engine for MedTech innovation in the global HealthTech marketplace.
For more information visit: www.relaymedical.com
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry.
For more information please visit: www.agraflora.com.
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for UXD described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at www.sedar.com
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/20/c6861.html
SOURCE: AgraFlora Organics International Inc.
SOURCE: Relay Medical Corp
Relay Medical Corp. W. Clark Kent, President, Relay Medical Corp., Office.
647-872-9982 ext. 2, TF. 1-844-247-6633 ext. 2, investor.relations@relaymedical.com;
Bernhard Langer, EU Investor Relations, Office. +49 (0) 177 774 2314, Email:
blanger@relaymedical.com; AgraFlora Organics International Inc., Derek Ivany,
President & CEO, For additional information: E: ir@agraflora.com, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
News Story
AgraFlora Organics Completes Acquisition of 100% Interest of Licensed Cannabis Producer AAA Heidelberg Inc.
19 Dec 2018 03:00 ET
CNW Group
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) (the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce the acquisition of 100% interest in the London, Ontario based licensed cannabis producer, AAA Heidelberg Inc.
In conjunction with the acquisition the Company has issued 12,216,509 common shares (the "Shares") at a deemed price of $0.1667 per share to the shareholders of AAA Heidelberg Inc. ("AAA Heidelberg") pursuant to the share exchange agreement entered into between the Company, AAA Heidelberg and the shareholders of AAA Heidelberg dated January 26, 2015. The completed share transfer has resulted in the acquisition of the remaining interest of the AAA Heidelberg licensed facility and the entity is now a wholly owned subsidiary of AgraFlora Organics International Inc.
"This acquisition marks a very important milestone in AgraFlora's growth initiative and designation as an official licensed cannabis production company." said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "This, combined with the Company's 2,200,000 square foot Delta Greenhouse facility places AgraFlora among the largest potential per square footage cannabis producers in Canada and we are focused on brining both facilities into revenue generating production in 2019."
AgraFlora's AAA Heidelberg personnel are currently working with Canopy Growth to initiate the first crop of high quality medical cannabis at the London, Ontario based facility.
In Delta, BC the Company continues the retrofit of the existing 2,200,000 square foot Delta Greenhouse Complex and operations are currently on schedule to complete 250,000 sq. ft. of flowering area by the end of the Q2 2019. AgraFlora intends on completing the total of 1,700,000 sq. ft. of flowering area by the end of 2019 and the final phase of the greenhouse retrofit is planned to include an additional 450,000 sq. ft. of flowering area scheduled for completion in the summer of 2020.
The shares issued pursuant to the Agreement and the debt settlements are subject to a four month hold period.
The acquisition of the remaining interest in licensed cannabis producer AAA Heidelberg follows AgraFlora's December 13, 2018 announcement of a supply agreement with Namaste Technologies Inc.'s wholly-owned subsidiary, Cannmart Inc. for the right of first refusal to purchase up to 10% of the total annual production from AgraFlora's large-scale Delta Greenhouse Complex. This represents up to 25,000,000 grams per year, at a price of $4 per gram.
As announced on December 10, 2018 the Company recently closed on a $7.5 million second tranche of a $40 million financing to be used exclusively to develop the Delta Greenhouse Complex. A total of $20 million have been raised with the remaining $20 million to be paid in two tranches of $5 million on January 15 and $15 million on March 1, 2018.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/19/c4231.html
SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: ir@agraflora.com, T: (778) 945-0348
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
AgraFlora Organics Provides Additional Information to Supply Agreement with Namaste Technologies
Canada NewsWire
VANCOUVER, Dec. 13, 2018
VANCOUVER, Dec. 13, 2018 /CNW/ - At the request of IIROC, AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to provide additional information to the news release earlier today announcing an agreement (the "Agreement") with Namaste Technologies Inc.'s ("Namaste") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) wholly-owned subsidiary, Cannmart Inc. ("Cannmart"), where Cannmart may purchase medical cannabis products from AgraFlora's Propagation Services Canada (PSC) greenhouse operations in Delta, BC, subject to approval of its cultivation and sales licenses by Health Canada.
Agraflora Organics International (CNW Group/AgraFlora Organics International Inc.)
Subject to the terms of the Agreement, Cannmart reserves the right of first refusal to purchase up to 10% of the total annual production from AgraFlora's large-scale Delta Greenhouse Complex, representing 25,000,000 grams, at a price of $4 per gram, or up to $100,000,000 per year with production costs estimated to be between 20-24 percent of total revenue.
When the 2,200,000 sq. ft. Delta Greenhouse Complex is fully operational in 2021, it is projected to have an annual capacity of 250,000,000 grams of high quality cannabis.
For additional information regarding the Delta Greenhouse Complex and an interview with Master Grower Ruben Houweling please visit
AgraFlora Organics to Focus on Cannabis Flowering in its 2,200,000 Square Foot Greenhouse
12 Dec 2018 05:00 ET
CNW Group
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce its joint venture company Propagation Services Canada is to focus on the cultivation of cannabis flowering plants and conduct propagation for its own internal needs.
"We have discovered the cannabis industry is not quite ready for outsourcing plant propagation and therefore will move to cultivate cannabis flowering plants due to the superior economics," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "The retrofit of the 2,200,000 square foot greenhouse is going very well, and we will be planting our first crop early next year. The economics of a 2,220,000 sq. ft. greenhouse complex producing approximately 0.12 kilogram per square foot of cannabis flower is staggering. We look forward to expanding our cultivation of cannabis flower to include the majority of our large-scale greenhouse floor space."
Propagation Services Canada is a joint venture between AgraFlora Organics, the Houweling's Group and Delta Organic Cannabis Corp. and is the process of retrofitting a large-scale greenhouse complex in Delta, BC. The 2,200,000 square foot complex will be readied for cannabis cultivation in three phases:
-- Phase 1 includes the retrofit of 350,000 square feet, including
100,000 post-production facilities, completion scheduled for Q2
2019;
-- Phase 2 includes an additional 1,450,000 square feet to be
completed by Q4 2019;
-- Phase 3 consists of 400,000 square feet scheduled for
completion in Q2 2020.
When completed early next year, the first phase of the retrofit will provide over 250,000 square feet of production space with an estimated annualized capacity of 30,000 kilograms of cannabis. Total production capacity is anticipated to be approximately 200,000 kilograms per year by late 2019 when the Phase 2 is completed, and in excess of 250,0000 kilograms annually when the third and final phase is completed in 2020.
The Delta greenhouse complex includes advanced growing systems for HVAC, watering and lighting. It includes its own natural gas co-gen energy plant which provides cost effective electricity for lighting and heating of the large-scale greenhouse. The result is a highly efficient and one of the most cost-effective growing operations in the industry.
Phase one of the retrofit includes site preparation for 250,000 square feet of flowering area, development of standard operation procedures, completion of security audit, development of overall security plan, and the ordering of long lead time items and planning with plant genetic experts in preparation for the first crop.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit www.agraflora.com and follow @agraflora on Twitter.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/12/c3655.html
SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: ir@agraflora.com, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
got them Thursday, was able to trade on Friday.
thanks
should happen very soon. I should be able to trade this stock by Thursday.
AgraFlora Organics Provides Update to 2,200,000 Square Foot Greenhouse Retrofit at Delta, BC and Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
19 Nov 2018 08:30 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to report on the progress of the retrofit of the large-scale greenhouse complex in Delta, BC. The retrofit of the 2,200,000 square foot complex has been split into three phases: Phase 1 includes the retrofit of 350,000 square feet, including post-production facilities, completion scheduled for Q1 2019; Phase 2 includes an additional 1,450,000 square feet to be completed by Q4 2019; and the final phase consisting of 400,000 square feet. Initial activities of the retrofit include site preparation for propagation operations including 250,000 square feet of flowering area, development of standard operation procedures and completion of security audit and development of overall plan, plus ordering of long lead time items and planning with plant genetic experts in preparation for the first crop.
"We are working aggressively to prepare the large-scale greenhouse complex in Delta, BC for the first 250,000 square feet of cannabis flowering and propagation plants," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "The retrofit of the 2,200,000 square foot greenhouse is on schedule and when completed and fully licensed will constitute the largest cannabis propagation operations in Canada and likely one of the largest cannabis flowering facilities in the world. We continue to work diligently toward our goal of becoming one of the premier cannabis companies in Canada."
The Company is also pleased to provide an update to the previously announced Equity Participation and Earn-In Agreement (the "Agreement") with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, for up to a $40 million investment at a price of approximately $0.45 per AGRA share for the development of a large-scale, 2,200,000 square foot commercial medical cannabis cultivation operation in Delta, British Columbia.
AGRA and DOCC have agreed to modify the Agreement payment terms announced on September 25, 2018 to the following draw down table:
-- October 18, 2018, DOCC advanced $12,500,000 for 5,572,755 PUF
Ventures Shares (pre-split);
-- November 30, 2018, DOCC to advance $7,500,000 for 16,718,265
post-split AgraFlora shares (3,343,653 pre-split shares);
-- January 15, 2019, DOCC to advance $5,000,000 for 11,145,510
post-split AgraFlora shares (2,229,102 pre-split shares);
-- March 1, 2019, DOCC to advance $15,000,000 for 33,436,530
post-split AgraFlora shares (6,687,306 pre-split shares).
Changes to the Agreement also result in modifications to the Earn-In Right to be exercised according to the following earn-in schedule from AGRA's current 50% portion of Propagation Services Canada Inc. ("PSC"):
-- DOCC has earned a 6.25% of PSC, by satisfaction of $12,500,000
of the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 7.5% (for a total of 20%) of PSC
by satisfaction of a further $15,000,000 of the defined
subscription obligations
The proceeds of the subscriptions are to be used exclusively to develop the Delta propagation complex consisting of 2,200,000 square feet of illuminated greenhouse space and 1,700,000 square feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.
The Company, a 35% shareholder of Solaris Nutraceuticals, also reports the Australian Office of Drug Control (ODC) has rejected Solaris' application for both a medicinal cannabis license and cannabis research license due to management's failure to provide certain documents and information in a timely manner. Key members of the Solaris board are currently collecting the missing documentation and information and hope to be a position to submit the information within the 90-day appeal time frame.
About Delta Organic Cannabis Corp.
DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit www.agraflora.com and follow @agraflora on Twitter.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/19/c5109.html
SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: ir@agraflora.com, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
AgraFlora Organics Provides Update to 2,200,000 Square Foot Greenhouse Retrofit at Delta, BC and Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
19 Nov 2018 08:30 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to report on the progress of the retrofit of the large-scale greenhouse complex in Delta, BC. The retrofit of the 2,200,000 square foot complex has been split into three phases: Phase 1 includes the retrofit of 350,000 square feet, including post-production facilities, completion scheduled for Q1 2019; Phase 2 includes an additional 1,450,000 square feet to be completed by Q4 2019; and the final phase consisting of 400,000 square feet. Initial activities of the retrofit include site preparation for propagation operations including 250,000 square feet of flowering area, development of standard operation procedures and completion of security audit and development of overall plan, plus ordering of long lead time items and planning with plant genetic experts in preparation for the first crop.
"We are working aggressively to prepare the large-scale greenhouse complex in Delta, BC for the first 250,000 square feet of cannabis flowering and propagation plants," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "The retrofit of the 2,200,000 square foot greenhouse is on schedule and when completed and fully licensed will constitute the largest cannabis propagation operations in Canada and likely one of the largest cannabis flowering facilities in the world. We continue to work diligently toward our goal of becoming one of the premier cannabis companies in Canada."
The Company is also pleased to provide an update to the previously announced Equity Participation and Earn-In Agreement (the "Agreement") with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, for up to a $40 million investment at a price of approximately $0.45 per AGRA share for the development of a large-scale, 2,200,000 square foot commercial medical cannabis cultivation operation in Delta, British Columbia.
AGRA and DOCC have agreed to modify the Agreement payment terms announced on September 25, 2018 to the following draw down table:
-- October 18, 2018, DOCC advanced $12,500,000 for 5,572,755 PUF
Ventures Shares (pre-split);
-- November 30, 2018, DOCC to advance $7,500,000 for 16,718,265
post-split AgraFlora shares (3,343,653 pre-split shares);
-- January 15, 2019, DOCC to advance $5,000,000 for 11,145,510
post-split AgraFlora shares (2,229,102 pre-split shares);
-- March 1, 2019, DOCC to advance $15,000,000 for 33,436,530
post-split AgraFlora shares (6,687,306 pre-split shares).
Changes to the Agreement also result in modifications to the Earn-In Right to be exercised according to the following earn-in schedule from AGRA's current 50% portion of Propagation Services Canada Inc. ("PSC"):
-- DOCC has earned a 6.25% of PSC, by satisfaction of $12,500,000
of the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 7.5% (for a total of 20%) of PSC
by satisfaction of a further $15,000,000 of the defined
subscription obligations
The proceeds of the subscriptions are to be used exclusively to develop the Delta propagation complex consisting of 2,200,000 square feet of illuminated greenhouse space and 1,700,000 square feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.
The Company, a 35% shareholder of Solaris Nutraceuticals, also reports the Australian Office of Drug Control (ODC) has rejected Solaris' application for both a medicinal cannabis license and cannabis research license due to management's failure to provide certain documents and information in a timely manner. Key members of the Solaris board are currently collecting the missing documentation and information and hope to be a position to submit the information within the 90-day appeal time frame.
About Delta Organic Cannabis Corp.
DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit www.agraflora.com and follow @agraflora on Twitter.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/19/c5109.html
SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: ir@agraflora.com, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
AgraFlora Organics Announces Completion of Name Change and Forward Split
14 Nov 2018 15:05 ET
CNW Group
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU3) (OTCPK: PUFXF), announces that, further to its news release of November 7, 2018, it has completed the name change from "PUF Ventures Inc." to "AgraFlora Organics International Inc." to better reflect the direction of the Company's business.
The Company's trading symbol has changed to "AGRA" on the Canadian Securities Exchange (the "CSE") and will remain as "PU3" on the Frankfurt Stock Exchange and as "PUFXF" on the OTC Pink sheets. The new CUSIP number for the Company's common shares is 00851F106 and ISIN is CA00851F1062.
The Company has been advised by the CSE that the common shares will commence trading under the new name effective at the opening of trading on November 15, 2018.
The Company is also pleased to announce that, following the name change, the Company will have completed a subdivision (the "Stock Split") of its issued and outstanding common shares on the basis of five (5) new common shares for every one (1) common share held by the shareholders of record (the "Registered Holders") as at November 19, 2018 (the "Record Date"). Consequently, Registered Holders as of the Record Date will receive five additional common shares for each common share held. In accordance with the Company's Articles, shareholder approval was not required for the Stock Split.
The Company's common shares are expected to commence trading on a split-adjusted basis on November 16, 2018.
"As we initiate cultivation at our AAA Heidelberg facility in London, ON and work toward the launch of our large-scale 2.2 million square foot greenhouse in Delta, BC, we felt it was necessary to change to a name more fitting to our goal of becoming a global leader in the cannabis sector," said Derek Ivany, President & CEO, AgraFlora Organics International Inc. "In addition to the name change to AgraFlora, the forward split is also a positive event for the Company as it provides for much greater liquidity for shareholders and allows for more transparent and consistent market."
Registered Holders do not need to take any action. The Company's transfer agent will send to all Registered Holders a notice under the direct registration system indicating the number of additional common shares that they received as a result of the Stock Split. These additional common shares will be held in book-entry form and registered electronically in the transfer agent's recordkeeping system, unless a physical share certificate is requested by the Registered Holder. Currently outstanding share certificates representing common shares of the Company will continue to be effective. They should be retained by Registered Holders and should not be forwarded to the Company or its transfer agent. Non-registered shareholders will have their brokerage accounts automatically updated to reflect the Stock Split.
After giving effect to the Stock Split, the Company will have approximately 340,671,315 common shares outstanding. The Company's authorized share capital will remain unchanged.
Outstanding stock options and share purchase warrants will also be adjusted by the Stock Split ratio and the respective exercise prices of outstanding stock options and share purchase warrants will be adjusted accordingly.
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit: www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE AgraFlora Organics International Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/14/c3957.html
SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: ir@agraflora.com, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
PUF Ventures Announces Proposed Name Change and Forward Split
07 Nov 2018 12:59 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), announces that it intends to change its name to "AgraFlora Organics International Inc." to better reflect the direction of the Company's business.
Concurrent with the name change, the Company will be completing a subdivision of its issued and outstanding common shares (the "Shares") on the basis of five (5) new Shares for every one (1) Share held.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/07/c8271.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
yes, received them over the weekend.
thanks
News Story
CSE: 2018-1102 - Plan of Arrangement - PUF Ventures Inc. (PUF)
01 Nov 2018 15:59 ET
GlobeNewswire
PUF Ventures Inc. ("PUF Ventures") has announced the completion of the arrangement and plan of arrangement (the "Arrangement") with Natures Hemp Corp. ("Natures Hemp"). In accordance with the Arrangement, the shareholders of PUF Ventures as at June 18, 2018, the record date for the special meeting that was held on August 7, 2018, will receive one common share of Natures Hemp for every 3.3665 common shares which they currently hold in PUF Ventures.
Disclosure documents are available at www.thecse.com
___________________________
PUF Ventures Inc. (<<PUF Ventures>>) a annonce la conclusion de l'arrangement et du plan d'arrangement (l '<<Arrangement>>) avec Natures Hemp Corp. (<<Natures Hemp>>). Conformement a l'arrangement, les actionnaires de PUF Ventures au 18 juin 2018, date de cloture des registres de l'assemblee extraordinaire tenue le 7 aout 2018, recevront une action ordinaire de Natures Hemp pour chaque tranche de 3,3665 actions ordinaires tenir dans PUF Ventures.
Les documents de divulgation sont disponibles sur www.thecse.com
Symbol(s)/Symbole(s): PUF
Ex-Distribution Date/ Date de distribution: June 15, 2018/ 15 juin 2018
Record Date/Date d'enregistrement: June 18, 2018/ 18 juin 2018
Distribution Date/ Date de distribution: August 28, 2018/ 28 aout 2018
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l'information supplementaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel a l'adresse: Listings@thecse.com
https://resource.globenewswire.com/media/02bcbc0c-7b2b-4503-8e3b-f55b7046b992/small/logo-en-png.png
<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzc0MjMyODg=" alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.
Chart not available
News Story
PUF Ventures Closes $12.5 Million First Tranche of $40 Million Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
18 Oct 2018 10:08 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), a growth oriented and diversified company focused on the international cannabis industry, announces that, further to its news releases dated September 25, 2018 and October 11, 2018, it has closed a $12.5 million first tranche of $40 million Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp. and issued the first tranche of 5,572,755 common shares (the "Shares") of the Company at a deemed price of $2.24 per Share.
"I am very please to report that we have received the first $12.5 million of a proposed $40 million financing to retrofit a 2.2 million square foot greenhouse for cannabis cultivation," said Derek Ivany, President and CEO, PUF Ventures Inc. "It has been a historic seven days for our Company with the granting of our license to produce from Health Canada, the legalization of cannabis in Canada and now the receipt of the initial funding from DOCC to retrofit a truly large-scale greenhouse in Delta, BC. These are significant milestones that have vaulted PUF Ventures into a prominent licensed producer. I have assembled a team of industry experts to oversee the retrofit and manage operations once complete and ensure the long-term success of the Company. I look forward to the days ahead as we move the Company from an applicant to a leading cannabis producer in Canada and around the world."
The Shares are being issued pursuant to the Equity Participation and Earn-In Agreement dated September 25, 2018 as amended on October 11, 2018, with Delta Organic Cannabis Corp., a privately held Toronto?based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise.
The Shares are subject to a statutory four-month hold period.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/18/c6727.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Marijuana Stocks for Investors in the Cannabis Investor Magazine October 2018 Issue
17 Oct 2018 12:49 ET
ACCESSWIRE
ATLANTA, GA / ACCESSWIRE / October 17, 2018 / CannaInvestor Magazine, the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced today that it has published its October 2018 issue of the Canadian CannaInvestor Magazine and the U.S. CannaInvestor Magazine. Both digital magazines are free to the public!
The content featured in the October 2018 Canadian CannaInvestor Magazine includes OrganiGram Holdings, Inc. (OGI) (OGRMF), PUF Ventures Inc. (PUF) (OTC PINK: PUFXF), Kontrol Energy Corp. (KNR) (OTC: OTSHF), Canadian Cannabis Stocks Technical Analysis, and the Top 25 Cannabis Companies. https://joom.ag/RbrY.
The content featured in the October 2018 U.S. CannaInvestor Magazine - Publicly Traded includes Kontrol Energy Corp. (OTSHF),Indiva Limited (NDVAF), GSRX Industries Inc. (GSRX), U.S. Cannabis Stocks Technical Analysis, and the Top 25 Cannabis Stocks. https://joom.ag/WTba.
The content featured in the October 2018 U.S. CannaInvestor Magazine - Privately Held includes Leafwire, Alternabis Farms, eXPO by Alliance Financial Network, and iaso Corp. https://joom.ag/mDVY.
Contact:
CannaInvestor Webcast & Magazine1-888-575-1254, Ext. 1team@cannainvestormag.comteam@cannainvestormag.ca
SOURCE: CannaInvestor Magazine
https://www.accesswire.com/img.ashx?id=525557
Copyright 2018 ACCESSWIRE
PUF Ventures Joins the Cannvas Marché Program as First Licensed Producer
16 Oct 2018 08:30 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), a growth oriented and diversified company focused on the international cannabis industry, is pleased to announce it has executed an agreement with Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, to become the first licensed producer to join the recently announced Cannvas Marché, a network of high-tech learning and fulfillment centres across Canada. PUF has secured premiere access to the digital experience screens to be presented in each Cannvas Marché location.
"I would like to welcome PUF Ventures as the first licensed producer to join our Cannvas Marché program," said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc. "The response to the launch of the new brand and concept has been incredible, as there is a definite lack of quality, unbiased, physician-backed information regarding the potential health benefits of cannabis. We are committed to improving access to cannabis education through a network of locations across the country and are engaged in discussions with various government bodies to accelerate the rollout. We will look to attract other leading licensed producers to join the Cannvas Marché program and contribute to the overall digital experience for customers."
"We share the concerns of leading politicians about the delivery of cannabis and feel by putting education at the forefront of this industry, we can take steps to reduce the risks associated with cannabis," said Derek Ivany, President and CEO of PUF Ventures Inc. "The concept to provide accessible and unbiased cannabis education to consumers at the point of purchase will be very attractive to large cities like Toronto, Montreal and Vancouver. The timing for the launch of the Cannvas Marché concept could not be better with legalization upon us. I look forward to working with Steve and Shawn and the rest of the team at Cannvas on the rollout of this impressive program to benefit the cannabis industry here in Canada and abroad."
With city and provincial governments stating concerns regarding the legalization of cannabis and its potential impact on neighbourhood safety and public health, PUF has teamed up with Cannvas to take a proactive approach to solving these issues. Cannvas Marché will improve accessibility to free and unbiased education on deriving the potential benefits of medical and adult-use cannabis, while providing consumers with retail options from leading cannabis brands.
Cannvas is working with top regulators and compliance bodies to begin the first phase of creating a network of this first-of-its-kind public cannabis education and fulfillment centres.
The Company intends to expand the reach of its Cannvas Marché centres to communities across Canada through a licensing model and leverage its strategic partnerships to further integrate the Cannvas.Me platform into existing retail experiences.
Operating under the brand Cannvas Marché, each location will feature digital learning resources, on-site medical and educational staff and a fulfillment program. Hands-on education sessions on a variety of cannabis-related topics will also be featured, but without the usual pressure to purchase or consume. The sessions will be led by a registered health practitioner or certified educator and showcase original physician-backed content created for the Cannvas.Me platform. Visitors can register for free seminars each week or drop in anytime.The first location is expected to open in Toronto in 2019.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/16/c1382.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF Ventures' Majority Owned Subsidiary Receives Cultivation License from Health Canada
15 Oct 2018 11:43 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), a growth oriented and diversified company focused on the international cannabis industry, is pleased to announce that its majority owned subsidiary, AAA Heidelberg Inc., has received its Access to Cannabis for Medical Purposes Regulations ("ACMPR") cultivation license from Health Canada. With this license, PUF Ventures is permitted to begin cultivating cannabis at its indoor facility located in London, Ontario.
"This is a very proud day for our Company and our loyal supporters alike," said Derek Ivany, President and CEO of PUF Ventures Inc. "Receiving a cultivation license from Health Canada is a significant achievement which positions PUF to become a leading cannabis supplier to legal medical and recreational markets, in Canada and around the world. As a partner of Canopy Growth Corporation's CraftGrow program, the Company looks forward to collaborating with CraftGrow to supply the marketplace with high quality cannabis. As we embark on this exciting next phase of growth, we are eager to expand our reach in both domestic and international cannabis markets."
With the receipt of the ACMPR cultivation license, AAA Heidelberg will begin preparing for the first crop of high-grade medical cannabis and PUF will move to immediately acquire the remaining ownership stake in the subsidiary.
In 2017, PUF partnered with Canopy Growth and joined its wholly-owned subsidiary, Tweed's CraftGrow program to sell the Company's medical cannabis. The CraftGrow program showcases the history, brand, and unique growing methods of each unique producer, with the goal of bringing select strains of high quality cannabis grown by a diverse set of producers to Tweed's registered customers. Through the partnership PUF's master grower will also work with Canopy's team to share expertise, technology, and best growing practices to maximize yield and ensure high quality product lines. PUF will also be able to source strains and lineage directly from Tweed's own breeding facility to add to its product line.
The granting of the ACMPR cultivation license from Health Canada follows announcements by PUF, on September 25 and October 11, 2018, regarding an equity participation and earn-in agreement with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by pre- eminent leaders in Canadian cannabis enterprise. Pursuant to the agreement, DOCC may provide up to a $40-million investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, B.C. The proceeds of the subscriptions are to be used exclusively to develop the Delta facility which currently consists of 2.2 million square feet of illuminated greenhouse space and 1.7 million square feet of ebb and flood irrigation space. It is currently anticipated that the first advance of funds by DOCC shall occur on October 17, 2018. Once the Delta Facility is permitted under the Cannabis Act, PUF Ventures will submit a second site cultivation license application for the facility.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/15/c2854.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
IIROC Trading Halt - PVOT; PUF
Canada NewsWire
VANCOUVER, Oct. 15, 2018
VANCOUVER, Oct. 15, 2018 /CNW/ - The following issues have been halted by IIROC:
Company: Pivot Pharmaceuticals Inc.
CSE Symbol: PVOT
Reason: At the request of the Company Pending News
Halt Time (ET): 8:15 AM
Company: PUF Ventures Inc.
CSE Symbol: PUF
Reason: At the request of the Company Pending News
Halt Time (ET): 8:15 AM
IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
View original content: http://www.newswire.ca/en/releases/archive/October2018/15/c5927.html
IIROC Inquiries 1-877-442-4322 (Option 2) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.Copyright CNW Group 2018
PUF Ventures Provides Update to Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
11 Oct 2018 08:30 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update to the previously announced Equity Participation and Earn-In Agreement (the "Agreement") with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, for up to a $40 million investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia.
PUF and DOCC have agreed to an extension to deadline for the first advance of funds by DOCC to PUF to October 17, 2018. As previously stated the completion of the transaction is subject to a number of conditions, including, but not limited to, completion of satisfactory due diligence, and the approval of the transaction by the Exchange, and the boards of directors of each of PUF and DOCC. Due to the size and complexity of the transaction, additional time is required to complete the transaction. All other terms of the contract do not change.
"We are working diligently to complete the transaction in a timely fashion," said Christopher MacIntyre, President of Delta Organic Cannabis Corp. "The scale and size of this project once converted will place us among a small but elite group of large-scale cannabis cultivation and propagation facilities."
"While PUF, DOCC and Propagation Services Canada are moving quickly to finalize the principal agreement, along with multiple ancillary and shareholder agreements relevant to this transaction, more time is necessary," said Derek Ivany, President and CEO of PUF Ventures. "We anticipate closing of the transaction by October 17, subject to Exchange and other approvals. The announcement of the transaction to fully fund the existing 2.2 million square foot greenhouse has generated significant inbound interest related to multiple important aspects of the go-forward business. The Delta Facility is poised to become one of the premier production sites for Canadian cannabis."
The proceeds of the subscriptions are to be used exclusively to develop the Delta propagation facility consisting of 2,200,000 square feet of illuminated greenhouse space and 1,700,000 square feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.
About Delta Organic Cannabis Corp.
DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/11/c7703.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF Ventures Congratulates Cannvas MedTech on the Launch of Cannvas.Me
09 Oct 2018 13:27 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to congratulate the team at Cannvas MedTech Inc. (CSE: MTEC) (Frankfurt: 3CM) for the launch of Cannvas.Me, an unbiased educational resource for medicinal and adult-use cannabis users which is now available online at http://Cannvas.Me.
In September 2017, PUF announced the spin-off of certain assets to form a company which subsequently became Cannvas MedTech.
"I would like to congratulate Shawn Moniz and Steve Loutskou of Cannvas MedTech on the launch of their first commercial online platform," said Derek Ivany, President and CEO of PUF Ventures. "We are on the eve of legalization and the cannabis space in Canada is in need of information and education that people can trust and rely on. Using advanced technology, Shawn and Steve have built an impressive web portal that delivers physician vetted content for both medicinal and recreational cannabis users. I wish Shawn and Steve and the rest of their team the very best on a successful launch and continued growth of their remarkable web portal."
Cannvas MedTech designs and builds customer-centric solutions that enable partners and clients to harness the power of data to truly understand their customers, industry, and key business drivers. The PUF spinout company has established itself as a leading business technology company in the cannabis health sciences space and began trading on the Canadian Stock Exchange with the symbol MTEC on July 3, 2018, and on the Frankfurt Exchange with the symbol 3CM on July 18, 2018.
Its first offering, Cannvas.Me, is a scalable, patient-centric life sciences learning platform for the global medical cannabis industry. Patients, consumers, medical practitioner and licensed producers, will use the Cannvas.Me platform for global interaction and cannabis education.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers. For additional information: www.cannvasmedtech.com.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/09/c3098.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF Ventures Congratulates Cannvas MedTech on the Launch of Cannvas.Me
09 Oct 2018 13:27 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to congratulate the team at Cannvas MedTech Inc. (CSE: MTEC) (Frankfurt: 3CM) for the launch of Cannvas.Me, an unbiased educational resource for medicinal and adult-use cannabis users which is now available online at http://Cannvas.Me.
In September 2017, PUF announced the spin-off of certain assets to form a company which subsequently became Cannvas MedTech.
"I would like to congratulate Shawn Moniz and Steve Loutskou of Cannvas MedTech on the launch of their first commercial online platform," said Derek Ivany, President and CEO of PUF Ventures. "We are on the eve of legalization and the cannabis space in Canada is in need of information and education that people can trust and rely on. Using advanced technology, Shawn and Steve have built an impressive web portal that delivers physician vetted content for both medicinal and recreational cannabis users. I wish Shawn and Steve and the rest of their team the very best on a successful launch and continued growth of their remarkable web portal."
Cannvas MedTech designs and builds customer-centric solutions that enable partners and clients to harness the power of data to truly understand their customers, industry, and key business drivers. The PUF spinout company has established itself as a leading business technology company in the cannabis health sciences space and began trading on the Canadian Stock Exchange with the symbol MTEC on July 3, 2018, and on the Frankfurt Exchange with the symbol 3CM on July 18, 2018.
Its first offering, Cannvas.Me, is a scalable, patient-centric life sciences learning platform for the global medical cannabis industry. Patients, consumers, medical practitioner and licensed producers, will use the Cannvas.Me platform for global interaction and cannabis education.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers. For additional information: www.cannvasmedtech.com.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/09/c3098.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Natures Hemp Formulates Hemp Based Coffee Creamer
Canada NewsWire
VANCOUVER, Oct. 2, 2018
Successful Trials by the University of Manitoba Lead to Healthy Alternative
VANCOUVER, Oct. 2, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that Natures Hemp Corp. ("Natures Hemp"), a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets, has reported the successful formulation and initial test results of a hemp based coffee creamer by the Richardson Centre of Functional Foods and Nutraceuticals at the University of Manitoba.
PUF Ventures (CNW Group/PUF Ventures)
"Working with the University of Manitoba, Natures Hemp formulated an all-natural, hemp-based, non-dairy coffee creamer which tastes good and has all the characteristics of conventional creamers without the worrying ingredients," said Derek Ivany, President and CEO of PUF Ventures. "Coffee drinkers are looking for a healthy alternative to conventional coffee creamers and Natures Hemp all-natural coffee creamer comes with all the healthy benefits of cannabidiols including: healthy omega-3 and omega-6 fatty acids, iron, vitamin E, and essential amino acids."
Hemp is traditionally known for its use in textiles due its long and strong fibers, but hemp seeds have become the source of a robust health food and alternative medicinal marketplace. Hemp seeds are being recognized as a superfood, like flax and chia seeds, because they are high in protein, contain 20 amino acids, and are also high in the fatty acids omega-3 and omega-6. Seeds are typically pressed to produce oil and the remaining byproduct is processed into a flour from which products like pasta, baked goods and other healthy foods can be created. Nature Hemp's healthy alternative non-dairy coffee creamer is made using the whole seed with added water.
Cannabidiol (CBD) is the naturally occurring compound found in the seeds, stalk and flowers of hemp plants. Scientific and clinical research is ongoing but early indications show that CBD is a potential treatment for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions. Potential health benefits from hemp food products include weight suppressant (high in fiber), immune-system booster, and an ability to lower blood pressure and cholesterol.
Natures Hemp is establishing a premium brand of quality CBD products, with an emphasis on health and wellness, in one of the fastest growing segments in the cannabis industry. The Company is focused at unlocking the true value of hemp by developing a new generation of plant-based, nutrient rich CBD food, beverage and healthcare related products.
About Natures Hemp Corp.
Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/02/c7042.html
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056Copyright CNW Group 2018
Natures Hemp Formulates Hemp Based Coffee Creamer
Canada NewsWire
VANCOUVER, Oct. 2, 2018
Successful Trials by the University of Manitoba Lead to Healthy Alternative
VANCOUVER, Oct. 2, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that Natures Hemp Corp. ("Natures Hemp"), a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets, has reported the successful formulation and initial test results of a hemp based coffee creamer by the Richardson Centre of Functional Foods and Nutraceuticals at the University of Manitoba.
PUF Ventures (CNW Group/PUF Ventures)
"Working with the University of Manitoba, Natures Hemp formulated an all-natural, hemp-based, non-dairy coffee creamer which tastes good and has all the characteristics of conventional creamers without the worrying ingredients," said Derek Ivany, President and CEO of PUF Ventures. "Coffee drinkers are looking for a healthy alternative to conventional coffee creamers and Natures Hemp all-natural coffee creamer comes with all the healthy benefits of cannabidiols including: healthy omega-3 and omega-6 fatty acids, iron, vitamin E, and essential amino acids."
Hemp is traditionally known for its use in textiles due its long and strong fibers, but hemp seeds have become the source of a robust health food and alternative medicinal marketplace. Hemp seeds are being recognized as a superfood, like flax and chia seeds, because they are high in protein, contain 20 amino acids, and are also high in the fatty acids omega-3 and omega-6. Seeds are typically pressed to produce oil and the remaining byproduct is processed into a flour from which products like pasta, baked goods and other healthy foods can be created. Nature Hemp's healthy alternative non-dairy coffee creamer is made using the whole seed with added water.
Cannabidiol (CBD) is the naturally occurring compound found in the seeds, stalk and flowers of hemp plants. Scientific and clinical research is ongoing but early indications show that CBD is a potential treatment for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions. Potential health benefits from hemp food products include weight suppressant (high in fiber), immune-system booster, and an ability to lower blood pressure and cholesterol.
Natures Hemp is establishing a premium brand of quality CBD products, with an emphasis on health and wellness, in one of the fastest growing segments in the cannabis industry. The Company is focused at unlocking the true value of hemp by developing a new generation of plant-based, nutrient rich CBD food, beverage and healthcare related products.
About Natures Hemp Corp.
Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/02/c7042.html
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056Copyright CNW Group 2018
PUF VENTURES INC (CA: PUF)
Last: 0.95 Change: 0.06 Volume: 489,154 Last Trade: 12:12
News Story
PUF Ventures Announces $40 Million Investment for Development of Large Scale Cannabis Cultivation Facility in Delta, B.C.
25 Sep 2018 15:42 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, today signed an Equity Participation and Earn-In Agreement (the "Agreement") which provides for up to $40 million in investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia. The proceeds of the subscriptions shall be used exclusively to develop the Delta propagation facility (the "Delta Facility") consisting of 2,200,000 sq. feet of illuminated greenhouse space and 1,700,000 sq. feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.
Derek Ivany, President & CEO of PUF, commented: "On behalf of our entire team, I am extremely pleased to announce the achievement of this marquee milestone for PUF. We have constantly strived to deliver shareholder value and I believe this significant financial commitment in support of our state-of-the-art greenhouse project in British Columbia demonstrates the tremendous value of this endeavour. In comparison to other existing large-scale cannabis cultivation facilities, the finalization of this project catapults PUF into the upper echelon of participants in the space." Mr. Ivany continued, "This sizeable financial commitment will provide enough capital to allow us to focus the majority of our strategy on high quality cannabis flowering while also still advancing the propagation service aspect of our business thus creating a more diversified revenue mix."
Christopher MacIntyre, President of DOCC, stated: "PUF has secured one of the largest existing greenhouses in Canada. With over $75 million already invested into the Delta facility, advanced growing technologies, access to power, and incredible personnel, the retrofit to cannabis production and licensing is anticipated to be swift." He continued, "We are also very pleased to be entering this joint venture as a shareholder of PUF. The fact that we will be acquiring PUF equity at over $2 per share reflects the excellent and exciting suite of assets that the Company has assembled over the past year."
Equity Participation and Subscription
Pursuant to the Agreement, DOCC shall subscribe for and purchase up to 17,832,816 common shares in the capital of PUF (the "Common Shares") at a price of $2.24 per PUF share, representing 19.9% of the issued and outstanding Common Shares of PUF on a fully diluted basis, in consideration for aggregate subscription proceeds of $40,000,000, such proceeds payable on the following draw down schedule:
-- On or before October 8, 2018, DOCC shall advance $12,500,000 in
subscription proceeds in exchange for 5,572,755 Common Shares;
-- On or before November 15, 2018, DOCC shall advance $7,500,000
in subscription proceeds in exchange for 3,343,653 Common
Shares;
-- On or before November 30, 2018, DOCC shall advance $5,000,000
in subscription proceeds in exchange for 2,229,102 Common
Shares;
-- On or before January 15, 2019, DOCC shall advance $5,000,000 in
subscription proceeds in exchange for 2,229,102 Common Shares;
and
-- On or before March 1, 2019, DOCC shall advance $10,000,000 in
subscription proceeds in exchange for 4,458,204 Common Shares.
For greater certainty, at no time during the currency of the Agreement shall DOCC hold greater than 19.9% of the issued and outstanding common shares of PUF.
Earn-In Rights
In consideration of DOCC's equity investment, PUF shall grant to DOCC the right to earn up to 20% (the "Earn-In Right") of PUF's ownership interest in and to Propagation Services Canada Inc. ("PSC"), owner of the Delta Facility. The Earn-In Right shall be exercised according to the following earn-in schedule from PUF's current 50% portion of PSC:
-- DOCC shall earn 6.25% of PSC, by satisfaction of $12,500,000 of
the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 15%) of PSC
by satisfaction of a further $5,000,000 of the defined
subscription obligations; and
-- DOCC shall earn an additional 5.0% (for a total of 20%) of PSC
by satisfaction of a further $10,000,000 of the defined
subscription obligations.
The completion of the transaction as contemplated by the Agreement is subject to a number of conditions, including, but not limited to, completion of satisfactory due diligence, and the approval of the transaction by the Exchange, and the boards of directors of each of PUF and DOCC.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
About Delta Organic Cannabis Corp.
DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/25/c4849.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
PUF VENTURES INC (CA: PUF)
Last: 0.95 Change: 0.06 Volume: 489,154 Last Trade: 12:12
News Story
PUF Ventures Announces $40 Million Investment for Development of Large Scale Cannabis Cultivation Facility in Delta, B.C.
25 Sep 2018 15:42 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, today signed an Equity Participation and Earn-In Agreement (the "Agreement") which provides for up to $40 million in investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia. The proceeds of the subscriptions shall be used exclusively to develop the Delta propagation facility (the "Delta Facility") consisting of 2,200,000 sq. feet of illuminated greenhouse space and 1,700,000 sq. feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.
Derek Ivany, President & CEO of PUF, commented: "On behalf of our entire team, I am extremely pleased to announce the achievement of this marquee milestone for PUF. We have constantly strived to deliver shareholder value and I believe this significant financial commitment in support of our state-of-the-art greenhouse project in British Columbia demonstrates the tremendous value of this endeavour. In comparison to other existing large-scale cannabis cultivation facilities, the finalization of this project catapults PUF into the upper echelon of participants in the space." Mr. Ivany continued, "This sizeable financial commitment will provide enough capital to allow us to focus the majority of our strategy on high quality cannabis flowering while also still advancing the propagation service aspect of our business thus creating a more diversified revenue mix."
Christopher MacIntyre, President of DOCC, stated: "PUF has secured one of the largest existing greenhouses in Canada. With over $75 million already invested into the Delta facility, advanced growing technologies, access to power, and incredible personnel, the retrofit to cannabis production and licensing is anticipated to be swift." He continued, "We are also very pleased to be entering this joint venture as a shareholder of PUF. The fact that we will be acquiring PUF equity at over $2 per share reflects the excellent and exciting suite of assets that the Company has assembled over the past year."
Equity Participation and Subscription
Pursuant to the Agreement, DOCC shall subscribe for and purchase up to 17,832,816 common shares in the capital of PUF (the "Common Shares") at a price of $2.24 per PUF share, representing 19.9% of the issued and outstanding Common Shares of PUF on a fully diluted basis, in consideration for aggregate subscription proceeds of $40,000,000, such proceeds payable on the following draw down schedule:
-- On or before October 8, 2018, DOCC shall advance $12,500,000 in
subscription proceeds in exchange for 5,572,755 Common Shares;
-- On or before November 15, 2018, DOCC shall advance $7,500,000
in subscription proceeds in exchange for 3,343,653 Common
Shares;
-- On or before November 30, 2018, DOCC shall advance $5,000,000
in subscription proceeds in exchange for 2,229,102 Common
Shares;
-- On or before January 15, 2019, DOCC shall advance $5,000,000 in
subscription proceeds in exchange for 2,229,102 Common Shares;
and
-- On or before March 1, 2019, DOCC shall advance $10,000,000 in
subscription proceeds in exchange for 4,458,204 Common Shares.
For greater certainty, at no time during the currency of the Agreement shall DOCC hold greater than 19.9% of the issued and outstanding common shares of PUF.
Earn-In Rights
In consideration of DOCC's equity investment, PUF shall grant to DOCC the right to earn up to 20% (the "Earn-In Right") of PUF's ownership interest in and to Propagation Services Canada Inc. ("PSC"), owner of the Delta Facility. The Earn-In Right shall be exercised according to the following earn-in schedule from PUF's current 50% portion of PSC:
-- DOCC shall earn 6.25% of PSC, by satisfaction of $12,500,000 of
the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 15%) of PSC
by satisfaction of a further $5,000,000 of the defined
subscription obligations; and
-- DOCC shall earn an additional 5.0% (for a total of 20%) of PSC
by satisfaction of a further $10,000,000 of the defined
subscription obligations.
The completion of the transaction as contemplated by the Agreement is subject to a number of conditions, including, but not limited to, completion of satisfactory due diligence, and the approval of the transaction by the Exchange, and the boards of directors of each of PUF and DOCC.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
About Delta Organic Cannabis Corp.
DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/25/c4849.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF VENTURES INC (CA: PUF)
Last: 0.79 Change: 0.00 Volume: 0 Last Trade: 09/20
News Story
PUF Ventures and Liberty Leaf Holdings Execute MOU to Form Joint Venture to Explore Cannabis Cultivation in Greece
20 Sep 2018 17:43 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (Frankfurt: HN3P), (together, "the Parties") a company in the business of acquiring partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis sector, are pleased to announce the execution of a Memorandum of Understanding ("MOU") which outlines the basis whereby the Parties will undertake the formation of a joint venture partnership for the purposes of developing a medical cannabis project for the cultivation and sale of medical cannabis in Greece. The joint venture company is currently in discussions with potential local partners with suitable resources and expertise to participate in the development of a large-scale, medical cannabis commercial cultivation operation.
"I am impressed with the work accomplished by Derek and his team in the international cannabis markets," said Will Rascan, President and CEO of Liberty Leaf Holdings. "We are looking to leverage our respective capabilities, combined knowledge and experience to successfully develop a large-scale commercial medical cannabis project in Greece."
"Europe has been in our sights for quite some time and I am pleased to partner with Will and the Liberty Leaf team to pursue a cannabis project in Greece," said Derek Ivany, President and CEO of PUF Ventures. "PUF has developed a successful business model whereby we identify friendly cannabis jurisdictions, partner with local experts, engage governments and academia, and design and build large-scale, eco-friendly, commercial cannabis cultivation operations. We are pursuing large-scale greenhouse projects in Australia and in Canada, and we believe that we have assembled the team to successfully navigate challenging regulatory environments and build highly efficient, low cost cannabis production facilities in Greece. I look forward to working with Liberty Leaf and bringing the PUF brand and business model to the great country of Greece."
Cannabis has a long history in Greece with the earliest mention of use found in fifth century BC Greek texts. Today there is significant interest to invest in local cultivation projects due to a new legal framework for medicinal cannabis brought in by the Greek government in 2017.
With the Greek economy experiencing many recent years of financial crisis, both federal and state government bodies are motivated to aid investment projects that can boost the economy and bring local employment. Furthermore, the relatively low cost for real estate and labour combined with regions of fertile land and warm dry climates, similar to California, there is an opportunity to produce low cost, high quality cannabis on a large-scale commercial basis.
Greece is also a natural gateway to the European Union, which is home to more than 500 million people, a population that is significantly larger than the population of the United States and Canada--the two largest cannabis markets in the world today.
The Parties will provide additional updates on joint venture formation, structure and business development in due course.
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply-chain products within this dynamic and fast-growing sector.
Liberty Leaf's late-stage ACMPR portfolio consists of a 60% interest in Just Kush and 100% of North Road Ventures. The company has launched its Signature Cannabis Retail division, an enterprise that is expected to roll out across Canada, bringing recreational cannabis to market for consumers. For further info on the Company please visit http://www.libleaf.com or email info@libleaf.com.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada and is actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/20/c2257.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF VENTURES INC (CA: PUF)
Last: 0.69 Change: -0.01 Volume: 70,499 Last Trade: 10:15
News Story
PUF Ventures Perfectly Positioned to Benefit from a Renewed Enthusiasm in the Canadian Cannabis Space
14 Sep 2018 16:17 ET
GlobeNewswire
Enthusiasm has returned to the legal cannabis space in Canada and PUF Ventures Inc. (CSE: PUF) (OTC: PUFXF), a late stage ACMPR license candidate, appears to be in perfect position to take advantage of the public's renewed interest. PUF has a proven track record of creating shareholder value through the pursuance of niche market opportunities, and in burgeoning sectors, such as the legal cannabis industry, niche market opportunities remain both innumerous and profitable. The rekindled enthusiasm in the space will begin to drive these niche markets, especially as the effective date of legalization (October 17, 2018) draws nearer, and PUF will be one of the few organizations already engaged in the unique and untapped market opportunities that currently exist.
Causes for Enthusiasm
Several events have signalled the return of enthusiasm to the legal cannabis market in Canada. Investors have been once again rallying behind the most popular companies in the space, causing the price of the Canadian Marijuana Index to increase nearly 100% in the last month. Continued regulatory reform has also increased confidence in the industry as Health Canada has made significant strides in the last two months, loosening the restrictions on hemp plant use. Finally, the Canadian cannabis market is starting to receive substantial investment from powerful international entities. Constellation Brands, probably best known in Canada for producing Corona, recently decided to invest an additional $5 billion into cannabis bellwether, Canopy Growth Corp. When Fortune 500 companies such as Constellation begin pouring billions of dollars into a burgeoning market, you can be certain that there is both spirited interest and immeasurable potential.
Identification of Emerging Trends and Track Record of Value Creation for Shareholders
The team at PUF Ventures has proven time and time again that they are exceptionally skilled at identifying emerging trends and harnessing them in a manner that creates considerable value for their shareholders. Late last year, PUF initiated a spin-out of its wholly owned subsidiary Cannvas Medtech, a leading business technology company within the health sciences space, and provided PUF shareholders with one MTEC share for every seven shares of PUF that they already owned. MTEC is now publicly traded as a stand-alone company and, as of the date of this release, possesses a market cap of more than $14 million and a share price of $0.38.
PUF has also expanded their pursuance of niche and emerging trends to markets outside of Canada. In 2017, PUF purchased a sizeable ownership stake in Solaris Nutraceuticals Pty. Ltd. Solaris Nutraceuticals is building a 1.2 million square foot greenhouse operation on a 27-hectare parcel of land near the town of Casino in northern New South Wales, Australia. When complete, the greenhouse will be one of the most technically advanced and environmentally sustainable medical cannabis operations in the world. It will include large-scale greenhouse, manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The first phase of the project will cover approximately 300,000 square feet, making it the largest medical cannabis greenhouse in Australia.
In recent months, PUF has also initiated another spin-out with its subsidiary Nature's Hemp, a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets. The Nature's Hemp spin-out will provide PUF shareholders with one share of Nature's Hemp for every 3.3665 shares of PUF owned as of June 18th, 2018.
Looking Ahead - Potential Cultivation Expansion
This past summer PUF secured a highly enviable potential expansion opportunity for large scale cannabis cultivation. PUF solidified a deal, via a 50/50 joint venture, granting them an exclusive 15-year license to a state of the art 2.2 million square foot greenhouse facility in Delta, BC. Further to the securement of this facility license, PUF also engaged industry consultants, Cannabis Compliance Inc., to aid them in preparing for the necessary regulatory-driven upgrades that the facility will need to undergo in order for large scale industrial cannabis cultivation to begin. This is a crucial component of the new endeavour as it means that PUF is well prepared to begin operations if, and when, they are awarded an ACMPR license.
This expansion potential grants PUF near term access to a facility that would otherwise take years and upwards of $100 million to build. In a market that is rapidly growing and evolving, this mechanism for cultivation expansion could indeed prove fruitful.
It is clear that PUF is in prime position to take advantage of the public's renewed enthusiasm in the cannabis space. They are continually seeking out new niche market opportunities and, while doing so, consistently creating value for their shareholders.
About PUF Ventures
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany, President & CEO
For additional information:
PUF Ventures Inc.
E: ir@puf.ca
T: (800) 783-6056
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release. Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
Global Objective Marketing
Do you want the same kind of exposure that PUF Ventures Inc. is receiving here? Contact Global Objective Marketing and we will produce professionally written press release content for your business and distribute it to any market that you wish to reach. For more information, please visit https://www.globalobjectivemarketing.com/.
This piece was written and distributed by Global Objective Marketing (GOM). All of the information contained within was produced using publicly available information and any opinions about individuals, companies or industries expressed within this release belong solely to GOM. The opinions expressed by GOM should not be considered as complete, accurate, or current investment advice. Any investment decisions made by readers are theirs and theirs alone. To ensure that you are making investment decisions that serve your own best interests, we recommend that you utilize the services of a professional financial planner or advisor. In order to comply with Section 17(b) of the 1933 Securities Act, GOM discloses that it was paid a sum of two thousand dollars CAD to write this content for PUF Ventures.
https://resource.globenewswire.com/media/c8e0be03-ec6d-466a-a781-46c54813a917/small/puf-ventures-logo-jpg.jpg
<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczNzc5Mzk=" alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.
PUF VENTURES INC (CA: PUF)
Last: 0.69 Change: -0.01 Volume: 65,764 Last Trade: 10:14
News Story
PUF Ventures Announces Greenhouse Project Update and Proposed Issuance of Shares
14 Sep 2018 14:40 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), announces that the Company is proceeding with the 2.2 million square foot greenhouse project located in Delta, British Columbia (the "Project") which was announced on June 29, 2018. The Company has been in discussions with potential financiers regarding financing of the Project, is in the process of finalizing sublease, management and shareholder agreements related to the Project, and has completed several site tours of the facility.
In conjunction with the Project, the Company plans to issue up to 4,000,000 common shares of the Company (the "Shares") for services to key personnel including related parties assisting with the Project. The Shares will be issued in tranches, with up to 2,000,000 Shares to be issued next week and up to 2,000,000 Shares to be issued on execution of the outstanding agreements related to the Project. The deemed value of the Shares will be determined by the closing market price on the day preceding the issuance of the Shares.
Additionally, the Company has paid a $1,500,000 deposit on the Project and has spent an additional $200,000 for the hiring of security personnel for the property.
The Company is also in discussions with various tissue culture experts and have shortlisted certain experts for potential partnerships.
About the Company
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg and Solaris Nutraceuticals Pty Ltd., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building one of the largest medical cannabis greenhouses. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/14/c8561.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF Ventures Announces Closing of Plan of Arrangement With Natures Hemp Corp.
Canada NewsWire
VANCOUVER, Aug. 28, 2018
VANCOUVER, Aug. 28, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), and Natures Hemp Corp. ("Natures Hemp") are pleased to announce that effective August 28, 2018 (the "Effective Date"), they completed a statutory arrangement under a plan of arrangement (the "Arrangement"). As a result of completing the Arrangement, Natures Hemp became a reporting issuer in the provinces of British Columbia, Alberta and Ontario.
PUF Ventures (CNW Group/PUF Ventures)
Completion of the Arrangement, as set forth in the arrangement agreement and plan of arrangement dated May 18, 2018 (the "Arrangement Agreement"), between PUF and Natures Hemp Corp. was approved by the shareholders of PUF on August 7, 2018 and by a Final Order granted by the Supreme Court of British Columbia on August 13, 2018, in accordance with Part 9 of the Business Corporations Act (British Columbia).
Natures Hemp Corp.:
Pursuant to the Arrangement Agreement and on the Effective Date, the following occurred:
(a)
PUF distributed 100% of the common shares of Natures Hemp ("Natures Hemp Shares") it received to the shareholders of PUF (the "PUF Shareholders") on a pro rata basis. The PUF Shareholders received one Natures Hemp Share in exchange for every 3.3665 common shares of PUF held as at the Record Date, June 18, 2018;
(b)
PUF transferred the assets to Natures Hemp;
(c)
Natures Hemp became a reporting issuer in the Provinces of British Columbia, Alberta and Ontario;
(d)
PUF retained its working capital for its assets, remains listed on the CSE and will continue to trade under the trading symbol, PUF, as a consumer products – biotechnology/pharmaceuticals company; and
(e)
Natures Hemp completed the conversion of 11,666,000 special warrants into Natures Hemp Shares.
The CUSIP number for the common shares of Natures Hemp is 639021104.
As of the Effective Date, the board of directors of Natures Hemp are Derek Ivany, David Parry and Robert V. Matthews and the officers of Natures Hemp are Derek Ivany, CEO and Sean McGrath, CFO.
About the Company
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of the release.
Some of the statements contained in the release are forward-looking statements, such as estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/28/c4206.html
regarding PUF Ventures Inc. or Natures Hemp Corp. please contact: Derek Ivany, President & CEO; For additional information: PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056Copyright CNW Group 2018
News Story
PUF Ventures and Natures Hemp Applaud Health Canada Changes to Industrial Hemp Regulations
15 Aug 2018 16:13 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Natures Hemp Corp., a biotechnology and consumer products company focused on unlocking the true value of the hemp for both B2B and B2C markets, commend Health Canada for the recent changes to Industrial Hemp Regulations and specifically the publication of the Subsection 56(1) Class Exemption in relation to the use of hemp under industrial hemp regulations (flowering heads, leaves and branches).
"Natures Hemp is developing nutrient rich cannabidiol (CBD) food, beverage and healthcare related products and we support any move to lessen the restrictions surrounding industrial hemp production," said Derek Ivany, President and CEO of PUF Ventures Inc. "With the legalization of cannabis in Canada on October 17, 2018, the changes are timely to allow hemp cultivators use the whole plant with their next harvest. It allows for the extraction of CBD from hemp to start immediately and provides a new revenue source for industrial hemp producers. We applaud Health Canada for this exemption to the industrial hemp regulations and the work they do for the cannabis industry."
The Health Canada exemption published by on August 10, 2018, allows licensed industrial hemp cultivator companies to begin to use the whole hemp plant for commercial purposes. Historically, cultivators were required to discard flowering heads, leaves and branches. Under the new exemption effective August 10, 2018, cultivators can harvest, dry, and store industrial hemp flowers, leaves, branches and other waste materials that contain valuable CBD content which can be used to produce food, beverage and other health related products.
About Natures Hemp Corp.
Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness. 2 Currently. Natures Hemp is a subsidiary of PUF. Pursuant to the previously announced plan of arrangement between Natures Hemp and PUF, if the plan of arrangement is approved by the shareholders of PUF and the court, it is expected that Natures Hemp will become a reporting issuer.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany, President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/15/c4914.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF Ventures Announces the Court Approval of the Plan of Arrangement and Closing of First Tranche of $0.25 Special Warrant Private Placement
14 Aug 2018 16:15 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), is pleased to announce that on August 13, 2018, the Supreme Court of British Columbia approved the plan of arrangement among PUF, Natures Hemp Corp. ("Natures Hemp") and the shareholders of PUF (the "Arrangement"). The Company will proceed to complete the Arrangement, which includes the issuance of shares to the PUF shareholders of record as of June 18, 2018, on the basis of one new common share in Natures Hemp for every 3.3665 PUF shares held on a pro rata basis. Natures Hemp will issue approximately 17,500,000 common shares of Natures Hemp to the PUF shareholders. The Company received shareholder approval to the Arrangement at the Company's special meeting held on August 7, 2018.
For more information about the Arrangement please see the information circular of the Company dated June 18, 2018 and subsequent news releases dated August 3, 2018 and August 8, 2018 available on www.sedar.com.
The Company also announces that Natures Hemp has closed the first tranche of its special warrant financing at a price of $0.25 per special warrant through the issuance of 1,676,000 special warrants for aggregate gross proceeds of $419,000. Each special warrant is convertible into common shares of Natures Hemp.
About the Company
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany, President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/14/c5815.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF Ventures Reports Special Meeting Results
Canada NewsWire
VANCOUVER, Aug. 8, 2018
VANCOUVER, Aug. 8, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), is pleased to announce the voting results of its Special Meeting held on August 7, 2018. A total of 10,492,782 common shares representing 17.81% of the issued shares of the Company were represented at the Meeting. All resolutions presented to the shareholders were approved (see the SEDAR filing of the Company's Information Circular dated June 18, 2018).
PUF Ventures (CNW Group/PUF Ventures)
Shareholders voted 98.4% in favour of the plan of arrangement, which involves the distribution of common shares of Natures Hemp Corp. ("Natures Hemp") to the shareholders of the Company and 98.3% in favour of the adoption of a 10% rolling stock option plan of Natures Hemp.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany, President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/08/c2758.html
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056Copyright CNW Group 2018
PUF Ventures Bringing Science of Plant Propagation to Medical and Recreational Cannabis Industry
31 Jul 2018 08:30 ET
GlobeNewswire
In an effort to differentiate itself from the emerging cannabis market in Canada, PUF Ventures Inc. (OTCPK: PUFXF) (CSE: PUF) (Frankfurt: PU3) has taken a novel approach to producing cannabis that should prove to be every bit as lucrative as growing it. With the idea of separating itself from the competition, the innovative Vancouver-based company partnered with Casey Houweling, who has 4 decades of experience with plant propagation, to form Propagation Services Canada Inc. (PSC), to introduce the concept of science-based vegetative propagation to the cannabis industry in Canada.
With the federal government in Canada passing Bill C-45 or the "Cannabis Act" and recreational cannabis becoming legal on October 17, 2018, the cannabis market in Canada has become an economic juggernaut. PUF Ventures will use its third party propagation services to navigate the landscape there and develop what should be an operation with long-term success in the industry.
While new to the cannabis industry, large-scale scientific vegetative propagation is commonplace in other plant markets like the tea industry and with many types of vegetables. The greatest benefit to using third party vegetative propagation in the cannabis industry is that it allows licensed producers the opportunity to use valuable floor space for growing revenue-generating flowering plants.
According to the analysis conducted by PUF while the company was reviewing opportunities within the Canadian cannabis industry, it learned that approximately 20 to 30 percent of a licensed producer's greenhouse is dedicated to cannabis propagation. If this area could be repurposed to grow flowering plants, licensed producers could, in turn, realize a similar increase in revenue.
Another advantage of vegetative propagation is that the new propagated plants contain the same genetic material and are essentially clones of the parent plant. Once the strain has been established with desired traits, it can be reproduced indefinitely. This is important when maintaining consistent quality and taste in products made from plants or crops such as teas, coffee, fruits and vegetables.
Propagation becomes especially important for commercial cannabis growers who want to reproduce the highest-quality cannabis with consistent strain genetics.
Large-scale cannabis propagation has become a reality in Canada due in large part to the efforts of Derek Ivany, President and CEO of PUF Ventures, and Casey Houweling, President of the Houweling's Group. The unlikely partnership comes from Ivany's quest to become a top-five licensed producer in Canada and Houweling's desire to leverage his 40 years of plant propagation experience, and a 2.2 million square-foot facility in Delta, British Columbia. The Delta facility is considered one of the most technologically advanced greenhouses in North America, offering full propagation services with an experienced staff in a facility with 18 megawatts of power.
"Over time I believe that cannabis will become a commodity with the price per gram dropping to levels close to the cost of production," said Derek Ivany. He continued by saying, "After a thorough analysis of the industry indicated that outsourcing plant propagation could bring significant benefits to the many licensed producers operating in Canada, we approached Casey Houweling to talk about a partnership. By specializing in an ancillary product, like propagation services, we can ensure that PUF's long-term revenue stream is optimized by offering high margin scientific expertise and high-quality products to the overall market."
By leveraging Casey Houweling's experience in plant propagation, PSC can ensure high quality clones without disease and contaminates and offer starter plants to the industry's growers that can help mitigate these challenges and focus on growing and processing flowering plants.
Experts agree.
PUF Ventures hired Cannabis Compliance Inc. to help it prepare the new commercial propagation facility in Delta, British Columbia. Cannabis Compliance is a cannabis consulting firm with more than 10 years experience providing risk mitigation, due diligence and regulatory compliance to commercial cannabis producers and resellers worldwide.
Nico Hache, Director of Compliance at Cannabis Compliance Inc., said of PSC's operations and its large-scale facility in British Columbia, "The combination of one of the most technically advanced greenhouse sites entering the cannabis industry and more than 40 years of propagation experience, is precisely what the cannabis industry requires to deliver clean, pure stock plants. The nursery plant mortality rate in the industry is very high due to the lack of facility and technical expertise to grow at scale. PSC has a facility, the technical expertise, and with a few modifications will change the way cannabis is grown. This expertise is what has been missing in the industry and will be welcomed by licensed producers."
PUF Ventures' Ivany added, "I believe that independent propagation services in the Canadian cannabis space will massively disrupt cannabis growing methods in a very positive way."
The value proposition that PSC brings to the licensed producers in the market is the specialized science of plant propagation, offering healthy flowering cannabis plants free of contaminates, pests and disease, less staffing requirements, and more greenhouse space to grow revenue-generating flowering plants--providing licensed producers with an advantage to optimize operations, reduce costs, increase revenue and ensure their long-term success in the industry.
In part 2 of our series highlighting PUF Ventures and its efforts to become part of the cannabis landscape in Canada, we'll focus on the benefits and economics of propagation and how PUF Ventures can improve topline revenue and bottom-line expenses for licensed producers.
Learn more about PUF Ventures and PSC at: www.puf.ca
About Stock Market Media Group
Stock Market Media Group is a Content Development IR firm offering a platform for corporate stories to unfold in the media with research reports, corporate videos, radio-style CEO interviews and feature news articles.
This article was written based upon publicly available information. Stock Market Media Group may from time to time include our own opinions about the companies, their business, markets and opportunities in our articles. Any opinions we may offer about any of the companies we write about are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of the securities we write about are solely your responsibility based on your own due diligence. Our publications are provided only as an informational aid, and as a starting point for doing additional independent research. We encourage you to invest carefully and read the investor information available at the web site of the U.S. Securities and Exchange Commission at: www.sec.gov. We also recommend, as a general rule, that before investing in any securities you consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks. We are not a registered broker, dealer, analyst, or adviser. We hold no investment licenses and may not sell, offer to sell or offer to buy any security. Our publications about any of the companies we highlight in our content are not a recommendation to buy or sell a security. Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b), we are disclosing that we were paid one thousand dollars from a third party via bank wire to produce content related to PUF Ventures.
For more information: www.stockmarketmediagroup.com.
Contact:
Stock Market Media Group
info@stockmarketmediagroup.com
Contact:
Stock Market Media Group
info@stockmarketmediagroup.com
https://resource.globenewswire.com/Resource/Download/74ad44f1-a584-4c98-a5fd-a5997fc8a954?size=1
<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczMzQzODk=" alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.